Employees: 829
Size Bajaj Consumer Care (BAJAJCON.NS) is an India Consumer Staples company (Household/Personal Care) with a market value of $560M, the 810th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹399.35 on 18 Nov 2026.
Performance Over six months the shares fell 24.2%, against -12.0% for the median peer and +3.8% for the India market (cap-weighted) — 7th lowest of 21 in its peer set.
Growth Revenue grew 28.6% over the last twelve months (peer median +8.9%); the operating margin is 21.5% (peer median 8.2%).
Valuation It trades at 19.7× forward earnings against a peer median of 19.9× (9th cheapest of 18).
Price implies For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +5%, so the hurdle is +10 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 41.3 points above its cost of capital (13.6% WACC).
Next results Next results expected around 3 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹13.1B | ₹11.5B | ₹9.52B | ₹9.69B | ₹9.50B |
| Revenue growth | — | +21% | -2% | +2% | — |
| Gross profit | ₹6.44B | ₹5.28B | ₹3.70B | ₹4.05B | ₹4.01B |
| EBITDA | ₹2.98B | ₹2.15B | ₹1.18B | ₹1.45B | ₹1.35B |
| Net income | ₹2.51B | ₹1.90B | ₹1.25B | ₹1.55B | ₹1.39B |
| Free cash flow | n/a | ₹1.87B | ₹911M | ₹1.53B | ₹1.33B |
| Capital expenditure | n/a | ₹335M | ₹58.0M | ₹48.2M | ₹64.1M |
| Total debt | ₹135M | ₹158M | ₹41.7M | ₹87.5M | ₹92.8M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | BAJAJCON.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -10.7% | -9.2% | 8th lowest of 21 |
| 6-month return | -24.2% | -12.0% | 7th lowest of 21 |
| Distance from 52-week high | -42.3% | -38.0% | 6th lowest of 21 |
| Revenue growth (TTM) | +28.6% | +8.9% | 4th highest of 21 |
| Operating margin | 21.5% | 8.2% | 2nd highest of 21 |
| Forward P/E | 19.7× | 19.9× | 9th cheapest of 18 |
| Growth the price implies (Req g, 7 yrs) | 14.8% | 2.8% | 4th most demanding of 15 |
| Growth delivered (Del g) | +5.0% | +7.1% | 5th lowest of 15 |
| Hurdle (Req g minus delivered) | +9.9 pp | -5.7 pp | 3rd most demanding of 15 |
| ROIC minus cost of capital | +41.3 pp | +3.2 pp | 2nd highest of 21 |
| EV / EBITDA | 15.8× | 9.8× | 2nd most expensive of 9 |
| Net debt / EBITDA | -1.7× | -0.9× | 3rd least indebted of 9 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Bajaj Consumer Care BAJAJCON.NS | India | $560M | -24% | +29% | 22% | 19.7× | 14.8% | +5.0% |
| PZ Cussons PZC.L | United Kingdom | $527M | +13% | +5% | 11% | 12.7× | -2.3% | -2.1% |
| Qingdao Kingking Applied Chemistry 002094.SZ | China | $454M | -26% | +3% | 4% | n/a | n/a | n/a |
| Hangzhou Haoyue Personal Care 605009.SS | China | $726M | -18% | +10% | 6% | 17.7× | 4.4% | +7.7% |
| Tianjin Yiyi Hygiene Products 001206.SZ | China | $429M | -15% | -8% | 9% | 19.9× | 1.9% | +6.3% |
| Milbon 4919.T | Japan | $743M | +48% | +8% | 14% | 25.7× | -3.3% | +8.2% |
| Lafang China 603630.SS | China | $414M | -19% | +5% | 3% | 37.6× | n/a | n/a |
| Jyothy Labs JYOTHYLAB.NS | India | $762M | -9% | +5% | 8% | 40.8× | 34.5% | +8.9% |
| Jinglv Environment Science & Technology 001230.SZ | China | $392M | -25% | +28% | 11% | 13.9× | n/a | n/a |
| SYoung 300740.SZ | China | $816M | -48% | +14% | 3% | 33.4× | 14.0% | +6.1% |
| Liuzhou Liangmianzhen 600249.SS | China | $379M | -19% | -11% | -7% | n/a | n/a | n/a |
| McBride MCB.L | United Kingdom | $377M | +7% | +1% | 6% | 8.4× | -0.7% | +6.5% |
| Galaxy Surfactants GALAXYSURF.NS | India | $845M | +22% | +30% | 9% | 17.6× | 18.5% | +13.7% |
| Cosmecca Korea 241710.KS | South Korea | $847M | +23% | +42% | 12% | 16.3× | n/a | n/a |
| Dencare (Chongqing) Oral Care 001328.SZ | China | $912M | +13% | +10% | 11% | 27.9× | 3.7% | +10.8% |
| Runben Biotechnology 603193.SS | China | $918M | -30% | +13% | 21% | 18.5× | 1.5% | +28.4% |
| Tongling Jieya Biologic Technology 301108.SZ | China | $933M | +56% | +24% | 5% | 52.5× | 28.5% | +0.8% |
| Noevir 4928.T | Japan | $978M | +7% | -3% | 28% | 20.4× | -12.8% | +4.1% |
| Hangzhou Coco Healthcare Products 301009.SZ | China | $316M | -26% | +10% | 0% | 110.7× | n/a | n/a |
| Shandong Hiking International 600735.SS | China | $309M | -28% | -11% | -2% | n/a | -7.5% | +1.5% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.04B | +15% | +74% | 18% | 11.8× | 11.3% | +49.0% |